Skip to Main Content

Paper Details

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
Pediatric Blood and Cancer
22
2022
Children, FOXO1, FOXO1 fusion, RMS, patients, rhabdomyosarcoma
Author NameAffiliation
Douglas S HawkinsSeattle Children's Hospital, University of Washington
  • 1 - 1

Datasets

Release 1.2